Treatment of leukemia with fibroblast-mediated interferon-alpha gene therapy alone or in combination with doxorubicin

Leukemia Research

Volumn 20, Issue 5, 1996, Pages 379-384

  Wang, Jianli ^a   Cao, Xuetao ^a   Zhang, Weiping ^a   Ye, Tianxing ^a   Tani, Kenzaburo ^b  

^a SECOND MILITARY MEDICAL UNIVERSITY   (China)

^b UNIVERSITY OF TOKYO   (Japan)

Author keywords

Chemotherapy; Doxorubicin; Fibroblast; Gene therapy; Immunotherapy; Interferon alpha; Leukemia

Indexed keywords

ALPHA INTERFERON; DOXORUBICIN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CELL CLONE; CELL GROWTH; CELL STRAIN 3T3; CONTROLLED STUDY; FEMALE; FIBROBLAST; GENE THERAPY; GENETIC TRANSFECTION; INTRAPERITONEAL DRUG ADMINISTRATION; LEUKEMIA; MOUSE; NONHUMAN; PRIORITY JOURNAL; SURVIVAL TIME;

EID: 0029973496     PISSN: 01452126     EISSN: None     Source Type: Journal    
DOI: 10.1016/0145-2126(95)00139-5     Document Type: Article

References (19)

1. Janik J. E. & Steis R. G. (1993) Interferon therapy for malignant and nonmalignant disease. In Clinical Applications of Cytokines: Role in Pathogenesis, Diagnosis and Therapy (Oppenheim J. J., Rossio J. L. & Gearing A. J. H., Eds), p. 135. Oxford University Press, New York.
2. Colombo M. P. & Forni G. (1994) Cytokine gene transfer into tumor inhibition and tumor therapy: where are we now? Immun. Today 15, 48.
3. 1-interferon gene transfer into metastatic Friend leukemia cells abrogated tumorigenicity in immunocompetent mice: antitumor therapy by means of interferon-producing cells. Cancer Res. 53, 1107.
4. + T cell-mediated tumor rejection and development of antitumor immunity. Comparative studies with IFN-gamma producing TS/A cells. J. Immun. 153, 4604.
5. Hathorn R. W., Tso C. L., Kaboo R., Pang S., Figlin R., Sawyers C., deKernion J. B. & Belldegrum A. (1994) In vitro modulation of invasive and metastatic potentials of human renal cell carcinoma by interleukin-2 and/or interferon-alpha gene transfer. Cancer 74, 1904.
6. Ogura H., Tani K., Ozawa K., Nagata S., Asano S. & Takaku F. (1990) Implantation of genetically manipulated fibroblasts into mice as antitumor α-interferon therapy. Cancer Res. 50, 5102.
7. Balkwill F. R. & Moodie E. M. (1984) Positive interactions between human interferon and cyclophosphamide or adriamycin in a human tumor model system. Cancer Res. 44, 904.
8. Welander C. E., Morgan T. M., Hornesley H. D., Trotta P. P. & Spiegel R. J. (1985) Combined recombinant human interferon alpha-2 and cytotoxic agents studied in a clonogenic assay. Int. J. Cancer 35, 721.
9. Karasuyama H. & Melchers F. (1988) Establishment of mouse cell lines which constitutively secrete large quantities of interleukin 2, 3, 4, or 5, using modified cDNA expression vectors. Eur. J. Immun. 18, 97.
10. Armstrong J. A. (1981) Cytopathic effect inhibition assay for interferon: microculture plate assay. Meth. Enzymol. 78, 381.
11. Anderson W. F. (1994) Gene therapy for cancer. Human Gene Ther. 5, 1.
12. Rosenberg S. A. (1992) The immunotherapy and gene therapy of cancer. J. clin. Oncol. 10, 180.
13. Seldon R. F., Skoskiewicz M. J., Howie K. B., Russell P. S. & Goodman H. M. (1987) Implantation of genetically engineered fibroblasts into mice: implications for gene therapy. Science 236, 714.
14. St. Louis D. & Verma I. M. (1988) An alternative approach to somatic cell gene therapy. Proc. natn. Acad. Sci. U.S.A. 85, 3150.
15. Chang P. L., Capone J. P. & Brown G. M. (1990) Autologous fibroblast implantation: feasibility and potential problems in gene replacement therapy. Molec. Biol. Med. 7, 461.
16. Cao X., Zhang W., Zhou Z., Yu Y. & Tao Q. (1994) Immune regulation and in vivo antitumor effect of fibroblast-mediated IL-2 gene therapy (abstract). Cancer Gene Ther. 1, 313.
17. Cao X., Cai R., Zhang W. & Ye T. (1994) Fibroblast-mediated IL-3, IL-6 gene therapy accelerate the hematopoietic recovery following high-dose chemotherapy (abstract). Cancer Gene Ther. 1, 324.
18. Yu Y., Cao X., Yang S., Xu X. & Ye T. (1994) Establishment of fibroblast-mediated interleukin 4 gene therapy. Chin. J. Microbiol. Immun. 14, 410.
19. Cao X., Zhang W., Gu S., Tao Q., Zhou Z., Zheng L. & Ye T. (1994) Experimental study on the augmentation of host immune functions by fibroblast-mediated human interleukin-6 gene therapy. Chin. J. Immun. 10, 8.